Blood Diagnostics, Inc. (BDI), one of the leading distributors of recombinant and plasma-derived pharmaceutical products, on May 18th announced immediate availability of HepaGam B, the first intravenous hepatitis B immune globulin approved by the FDA.
Get the full story...
